|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of premium (discount) on marketable securities | |||||
| Amortization of debt discount | |||||
| Change in fair value of warrant liability | |||||
| Non-cash stock compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Contract receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale or maturity of marketable securities | |||||
| Purchases of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from notes payable and warrants | |||||
| Debt issuance costs associated with notes payable and warrants | |||||
| Proceeds from common stock offerings and warrants, net | |||||
| Proceeds from convertible preferred stock offering and warrants, net | |||||
| Proceeds from stock option exercises and employee stock plan purchases | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (IN THOUSANDS): | |||||
| Interest on debt | |||||
| Income taxes | |||||
Loading...
